Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stem cell exosomes as nanotherapeutics for dry age-related macular degeneration
Yue Tang, Yueyue Kang, Xinru Zhang, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 356-370
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications
Chunhao Yang, Yunxin Xue, Yu Duan, et al.
Journal of Controlled Release (2024) Vol. 365, pp. 1089-1123
Closed Access | Times Cited: 40
Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks
Popat Kumbhar, Kaustubh Kolekar, Sukriti Vishwas, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102322-102322
Closed Access | Times Cited: 14
The significance of precisely regulating heme oxygenase-1 expression: Another avenue for treating age-related ocular disease?
Wei Dong, Chengkang Qu, Na Zhao, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102308-102308
Closed Access | Times Cited: 6
Emerging role of mesenchymal stem cells-derived extracellular vesicles in vascular dementia
Ziying Liu, Lin Cheng, Lushun Zhang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases
Yun Su, Moxin Chen, Wei Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 22793-22828
Open Access | Times Cited: 5
Age-Related Macular Degeneration (AMD): Pathophysiology, Drug Targeting Approaches, and Recent Developments in Nanotherapeutics
Mahendra Pratap Singh, Riyakshi Negi, Alka, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1647-1647
Open Access | Times Cited: 4
Co-delivery of antioxidants and siRNA-VEGF: promising treatment for age-related macular degeneration
Marina França Dias, Estael Luzia Coelho da Cruz-Cazarim, Frederico Pittella, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Exosome-hybridized hydrogel acts as a foamy protective coat for the liver
Y. Liang, Shilun Li, Yixiao Pan, et al.
Chinese Chemical Letters (2025), pp. 110841-110841
Closed Access
Exosomes in Ocular Health: Recent Insights into Pathology, Diagnostic Applications and Therapeutic Functions
Noelia Blanco-Agudín, Suhui Ye, Sara González-Fernández, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 233-233
Open Access
Exosome’s Implications in Age-Related Macular Degeneration
Ali Torkashvand, Amir Reza Hajrasouliha
Current Eye Research (2025), pp. 1-8
Closed Access
Exosomes and Exosome-Derived miRNAs: Current Knowledge and Future Aspects
Ke Mao
IntechOpen eBooks (2025)
Closed Access
Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: a promising strategy for treating retinal degenerative diseases
Wenjing An, Wenliang Zhang, Qi Jia, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
MSC Exosomes and MSC Exosomes Loaded with LncRNA H19 as Nanotherapeutics Regulate the Neurogenetic Potential of Müller Glial Cells in Dry Age-Related Macular Degeneration
Yue Tang, Caiyi Cheng, Rui Ding, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Baicalein nanoemulsion in situ GEL for dry age-related macular degeneration
Wanbing Pan, Rong Sun, Ying Yu, et al.
International Journal of Pharmaceutics (2025), pp. 125494-125494
Closed Access
Exosomes in treating Eye Diseases: Targeting strategies
Pengfei Ge, Jingfan Wang, Ping Xie, et al.
Life Sciences (2025), pp. 123598-123598
Closed Access
Mechanism of mesenchymal stem cells and exosomes in the treatment of age-related diseases
Jia Li, Yuling Huang, Haiyan Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Induced pluripotent stem cell-derived mesenchymal stem cells: whether they can become new stars of cell therapy
Zewen Wu, Yazhen Su, Jingxuan Li, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Human amniotic mesenchymal stem cells-derived conditioned medium and exosomes alleviate oxidative stress-induced retinal degeneration by activating PI3K/Akt/FoxO3 pathway
Zhe-Qing Peng, Xiao‐Hui Guan, Zhenping Yu, et al.
Experimental Eye Research (2024) Vol. 244, pp. 109919-109919
Open Access | Times Cited: 2
Fully Bioactive Nanodrugs: Stem Cell-Derived Exosomes Engineered with Biomacromolecules to Treat CCl4- and Extreme Hepatectomy-Induced Acute Liver Failure
Meng Sun, Min Li, Min Hu, et al.
ACS Nano (2024) Vol. 18, Iss. 50, pp. 33907-33921
Closed Access | Times Cited: 2
Hypoxic preconditioned MSCs-derived small extracellular vesicles for photoreceptor protection in retinal degeneration
Yuntong Sun, Yuntao Sun, Shenyuan Chen, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Small Extracellular Vesicles And Oxidative Pathophysiological Mechanisms In Retinal Degenerative Diseases
Francisco J. Romero, Manuel Díaz-Llopis, M. Inmaculada Romero-Gomez, et al.
(2024)
Open Access | Times Cited: 1
Small Extracellular Vesicles and Oxidative Pathophysiological Mechanisms in Retinal Degenerative Diseases
Francisco J. Romero, Manuel Díaz-Llopis, M. Inmaculada Romero-Gomez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1618-1618
Open Access | Times Cited: 1
Targeting the Ophthalmic Diseases Using Extracellular Vesicles ‘Exosomes’: Current Insights on Their Clinical Approval and Present Trials
Hanxiang Yu, Jinsong Wu, Gaoxiang Pan
Aging and Disease (2024)
Open Access | Times Cited: 1
Melanin‐Like Nanomedicine Functions as a Novel RPE Ferroptosis Inhibitor to Ameliorate Retinal Degeneration and Visual Impairment in Dry Age‐Related Macular Degeneration
Keke Huang, Hongkuan Deng, Shuang Wang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 30
Closed Access | Times Cited: 1
Stem Cell-Derived Exosomes: Natural Intercellular Messengers with Versatile Mechanisms for the Treatment of Diabetic Retinopathy
Yameng Song, Caiyun Yin, Ning Kong
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10767-10784
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top